[HTML][HTML] Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)

R Seifert, L Emmett, SP Rowe, K Herrmann… - European Urology, 2023 - Elsevier
Context Prostate-specific membrane antigen (PSMA) targeting positron emission
tomography (PET) is emerging to become a reference imaging tool for the staging and …

Deep learning for medical image-based cancer diagnosis

X Jiang, Z Hu, S Wang, Y Zhang - Cancers, 2023 - mdpi.com
Simple Summary Deep learning has succeeded greatly in medical image-based cancer
diagnosis. To help readers better understand the current research status and ideas, this …

Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter …

TA Hope, M Eiber, WR Armstrong, R Juarez… - JAMA …, 2021 - jamanetwork.com
Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

WP Fendler, M Eiber, M Beheshti, J Bomanji… - European journal of …, 2023 - Springer
Here we aim to provide updated guidance and standards for the indication, acquisition, and
interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics …

[HTML][HTML] PSMA PET/CT for primary staging of prostate cancer-an updated overview

MR Jochumsen, K Bouchelouche - Seminars in Nuclear Medicine, 2024 - Elsevier
Prostate-specific membrane antigen PET/CT for primary staging of prostate cancer is
becoming increasingly popular due to simultaneous assessment of whole-body disease …

The PRIMARY score: using intraprostatic 68Ga-PSMA PET/CT patterns to optimize prostate cancer diagnosis

L Emmett, N Papa, J Buteau, B Ho, V Liu… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Multiparametric MRI (mpMRI) is validated for the diagnosis of clinically significant prostate
cancer (csPCa). 68Ga-PSMA-11 PET/CT (68Ga-PSMA PET/CT) combined with mpMRI has …

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping

EW Warner, K Van der Eecken, AJ Murtha, EM Kwan… - Nature Cancer, 2024 - nature.com
De novo metastatic prostate cancer is highly aggressive, but the paucity of routinely
collected tissue has hindered genomic stratification and precision oncology. Here, we …

Using PSMA imaging for prognostication in localized and advanced prostate cancer

MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission …

VH Meissner, I Rauscher, K Schwamborn, J Neumann… - European Urology, 2022 - Elsevier
A biopsy-free diagnostic pathway in prostate cancer (PC) is limited by the diagnostic
accuracy of multiparametric magnetic resonance imaging (mpMRI). The improved accuracy …

Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis

S Huang, S Ong, D McKenzie, A Mirabelli… - Prostate Cancer and …, 2023 - nature.com
Background Prostate-specific membrane antigen (PSMA) positron emission tomography
(PET)/computed tomography (CT) has become an increasingly established imaging …